Comorbidity of GJB2 and WFS1 mutations in one family

Gene

Volumn 501, Issue 2, 2012, Pages 193-197

  Minami, Shujiro B ^a   Masuda, Sawako ^b   Usui, Satoko ^b   Mutai, Hideki ^a   Matsunaga, Tatsuo ^a  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^b NHO Mie Hospital   (Japan)

Author keywords

Connexin 26; DFNA6 14; DFNB1; Hereditary hearing loss; Wolframin

Indexed keywords

ARGININE; CONNEXIN 26; ISOLEUCINE; PROLINE; PROTEIN; TRYPTOPHAN; UNCLASSIFIED DRUG; VALINE; WOLFRAMIN PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; COMORBIDITY; GENE MUTATION; HEARING LOSS; HETEROZYGOSITY; HUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL;

BASE SEQUENCE; CONNEXINS; EXONS; FEMALE; HEARING LOSS; HEARING TESTS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFANT; MALE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 84860729213     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.03.060     Document Type: Article

References (27)

1. Angeli S.I. Phenotype/genotype correlations in a DFNB1 cohort with ethnical diversity. Laryngoscope 2008, 118:2014-2023.
2. Bespalova I.N., et al. Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum. Mol. Genet. 2001, 10:2501-2508.
3. Bom S.J., Van Camp G., Cryns K., Admiraal R.J., Huygen P.L., Cremers C.W. Autosomal dominant low-frequency hearing impairment (DFNA6/14): a clinical and genetic family study. Otol. Neurotol. 2002, 23:876-884.
4. Brodwolf S., Boddeker I.R., Ziegler A., Rausch P., Kunz J. Further evidence for linkage of low-mid frequency hearing impairment to the candidate region on chromosome 4p16.3. Clin. Genet. 2001, 60:155-160.
5. Cryns K., et al. Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum. Mutat. 2003, 22:275-287.
6. Cryns K., et al. The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells. Histochem. Cell Biol. 2003, 119:247-256.
7. Cryns K., et al. A genotype-phenotype correlation for GJB2 (connexin 26) deafness. J. Med. Genet. 2004, 41:147-154.
8. Dai P., et al. GJB2 mutation spectrum in 2,063 Chinese patients with nonsyndromic hearing impairment. J. Transl. Med. 2009, 7:26.
9. Estivill X., et al. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 1998, 351:394-398.
10. Gurtler N., et al. Two families with nonsyndromic low-frequency hearing loss harbor novel mutations in Wolfram syndrome gene 1. J. Mol. Med. 2005, 83:553-560.
11. Higashi K. Otologic findings of DIDMOAD syndrome. Am. J. Otol. 1991, 12:57-60.
12. Inoue H., et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet. 1998, 20:143-148.
13. ISO (International Organization for Standardization) ISO 7029-2000: Acoustics-Statistical Distribution of Hearing Thresholds as a Function of Age 2000, International Organization for Standardization, Geneva. 2nd ed.
14. Kunst H., Marres H., Huygen P., Van Camp G., Joosten F., Cremers C. Autosomal dominant non-syndromal low-frequency sensorineural hearing impairment linked to chromosome 4p16 (DFNA14): statistical analysis of hearing threshold in relation to age and evaluation of vestibulo-ocular functions. Audiology 1999, 38:165-173.
15. Lesperance M.M., Hall J.W., San Agustin T.B., Leal S.M. Mutations in the Wolfram syndrome type 1 gene (WFS1) define a clinical entity of dominant low-frequency sensorineural hearing loss. Arch. Otolaryngol. Head Neck Surg. 2003, 129:411-420.
16. Maeda S., et al. Structure of the connexin 26 gap junction channel at 3.5 A resolution SUPPLEMENTARY INFORMATION. Nature 2009, 458:597-602.
17. Matsunaga T. Value of genetic testing in the otological approach for sensorineural hearing loss. Keio J. Med. 2009, 58:216-222.
18. Matsunaga T., Hirota E., Bito S., Niimi S., Usami S. Clinical course of hearing and language development in GJB2 and non-GJB2 deafness following habilitation with hearing aids. Audiol. Neurootol. 2006, 11:59-68.
19. Morell R.J., et al. Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N. Engl. J. Med. 1998, 339:1500-1505.
20. Ohtsuka A., et al. GJB2 deafness gene shows a specific spectrum of mutations in Japan, including a frequent founder mutation. Hum. Genet. 2003, 112:329-333.
21. Pennings R.J., et al. Progression of low-frequency sensorineural hearing loss (DFNA6/14-WFS1). Arch. Otolaryngol. Head Neck Surg. 2003, 129:421-426.
22. Smith R.J., Bale J.F., White K.R. Sensorineural hearing loss in children. Lancet 2005, 365:879-890.
23. Snoeckx R.L., et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am. J. Hum. Genet. 2005, 77:945-957.
24. Strom T.M., et al. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum. Mol. Genet. 1998, 7:2021-2028.
25. Young T.L., et al. Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1. Hum. Mol. Genet. 2001, 10:2509-2514.
26. Zatyka M., et al. Sodium-potassium ATPase 1 subunit is a molecular partner of wolframin, an endoplasmic reticulum protein involved in ER stress. Hum. Mol. Genet. 2008, 17:190-200.
27. Zdebik A.A., Wangemann P., Jentsch T.J. Potassium ion movement in the inner ear: insights from genetic disease and mouse models. Physiology (Bethesda) 2009, 24:307-316.